Is LLY a good stock to buy? We came across a bullish thesis on Eli Lilly and Company on Investomine’s Substack. In this ...
Eli Lilly (NYSE:LLY) stock is down 5% in Tuesday afternoon trading, with shares falling to $937 from a prior close of $989.12 ...
Stocktwits on MSN
LLY shares dive on analyst downgrade citing obesity market overestimation concerns, but retail dismisses 'absurd' selloff
The analyst now thinks that expectations for obesity drugs’ total addressable market are elevated at over $150 billion.
Eli Lilly (LLY) stock is lower today, after HSBC downgraded it to "reduce" from "hold," citing an inflated obesity drug market ...
Eli Lilly (LLY) stock declined after HSBC downgrade to Reduce with $850 price target, citing obesity drug market risks and ...
Eli Lilly (NYSE:LLY) shares have pulled back sharply, falling 9% over the past month, and 13% year-to-date. Most Wall Street ...
Eli Lilly LLY and Novo Nordisk NVO, long-standing rivals and the two dominant forces in the GLP-1 obesity market, are now locked in an intensified battle as both companies slash prices to defend and ...
HSBC downgraded this dividend-paying health care giant. Here's what investors should know before the obesity drug race heats ...
The way that people discuss LLY these days is virtually unique. Quieter tones—almost like a mutual understanding among ...
Biggest stock gainers. Lemonade +15% - Shares gained after Morgan Stanley upgraded the stock to Overweight from Equal-Weight, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results